Literature DB >> 21576897

Understanding glycemic control in the critically ill: 2011 update.

James S Krinsley1.   

Abstract

Intensive monitoring of blood glucose concentrations in critically ill patients has become a standard of care in intensive care units over the past 10 years, following the publication of a single-center randomized trial targeting euglycemia in postoperative patients. This article summarizes the literature describing the relationship between hyperglycemia and mortality in the critically ill, the main findings of the major interventional trials of intensive insulin therapy, the association between hypoglycemia and increased glycemic variability with adverse outcomes, and the impact of a preexisting diagnosis of diabetes. A framework for understanding dysglycemia in the critically ill, an approach that recognizes disturbances in the "3 domains" of glycemic control--hyperglycemia, hypoglycemia, and increased glycemic variability--is presented. Finally, practical considerations relating to the implementation of glycemic management protocols are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576897     DOI: 10.3810/hp.2011.04.394

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  3 in total

1.  Glucose measurement of intensive care unit patient plasma samples using a fixed-wavelength mid-infrared spectroscopy system.

Authors:  James Krinsley; Kelly Bochicchio; Christopher Calentine; Grant Bochicchio
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

2.  Independent Association of Glucose Variability With Hospital Mortality in Adult Intensive Care Patients: Results From the Australia and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation Binational Registry.

Authors:  Hemant Kulkarni; Shailesh Bihari; Shivesh Prakash; Sue Huckson; Shaila Chavan; Manju Mamtani; David Pilcher
Journal:  Crit Care Explor       Date:  2019-08-01

3.  Risk and reward: extending stochastic glycaemic control intervals to reduce workload.

Authors:  Vincent Uyttendaele; Jennifer L Knopp; Geoffrey M Shaw; Thomas Desaive; J Geoffrey Chase
Journal:  Biomed Eng Online       Date:  2020-04-29       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.